Karin Heidemann
Hoofd Techniek/Wetenschap/O&O bij CHAMPIONS ONCOLOGY, INC.
Actieve functies van Karin Heidemann
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-2019 | - |
Loopbaan van Karin Heidemann
Eerdere bekende functies van Karin Heidemann
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Rockland Immunochemicals, Inc.
 Rockland Immunochemicals, Inc. BiotechnologyHealth Technology Rockland Immunochemicals, Inc. is a biotech company that was founded in 1962. The private company is based in Limerick, PA and has subsidiaries in the United States and Germany. The company specializes in manufacturing cutting-edge tools for basic, applied, and clinical research. The company offers custom anti-id antibodies for specific therapeutic development and tissue powders that can be used as a specific adsorbent to remove unwanted reactivities or as source material. The CEO of Rockland Immunochemicals is James Fendrick. | Corporate Officer/Principal | 01-03-2017 | 01-09-2019 |
Opleiding van Karin Heidemann
| Universität zu Köln | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Duitsland | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CHAMPIONS ONCOLOGY, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Rockland Immunochemicals, Inc.
Rockland Immunochemicals, Inc. BiotechnologyHealth Technology Rockland Immunochemicals, Inc. is a biotech company that was founded in 1962. The private company is based in Limerick, PA and has subsidiaries in the United States and Germany. The company specializes in manufacturing cutting-edge tools for basic, applied, and clinical research. The company offers custom anti-id antibodies for specific therapeutic development and tissue powders that can be used as a specific adsorbent to remove unwanted reactivities or as source material. The CEO of Rockland Immunochemicals is James Fendrick. | Health Technology |
- Beurs
- Insiders
- Karin Heidemann
- Ervaring
